All In Biotech

Drug Trial Radar · NCT07645248

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

A Randomized, Double-blind, 2-way Crossover, Multicenter Study to Evaluate the Safety of Test Propellant HFA-152a and Reference Propellant HFA-134a When Administered Via Metered Dose Inhalers

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 110 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

110

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Dec 28, 2026

Study completion Dec 28, 2026

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Jun 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to generate additional safety data on the propellant component of the reformulated product by comparing metered dose inhaler (MDIs) containing HFA-152a (test) with HFA-134a (reference).

Conditions

  • Asthma

Interventions

  • HFA-152aDrug

    HFA-152a will be administered.

  • HFA-134aDrug

    HFA-134a will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events (AEs)Time frame: Up to 8 weeks

Locations

20 sites in 4 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Aventura, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Naples, Florida · Recruiting

  • GSK Investigational Site

    Owensboro, Kentucky · Recruiting

  • GSK Investigational Site

    Columbia, Missouri · Recruiting

  • GSK Investigational Site

    Henderson, Nevada · Recruiting

  • GSK Investigational Site

    Medford, Oregon · Recruiting

  • GSK Investigational Site

    Spartanburg, South Carolina · Recruiting

  • GSK Investigational Site

    Spartanburg, South Carolina · Recruiting

  • GSK Investigational Site

    Cypress, Texas · Recruiting

  • GSK Investigational Site

    Tomball, Texas · Recruiting

  • GSK Investigational Site

    Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    Ciudad Autonoma de Buenos Aire, Argentina · Recruiting

  • GSK Investigational Site

    Lujan de Cuyo, Argentina · Recruiting

  • GSK Investigational Site

    Ajax, Ontario, Canada · Recruiting

  • GSK Investigational Site

    Québec, Quebec, Canada · Recruiting

  • GSK Investigational Site

    Trois-Rivières, Quebec, Canada · Recruiting

  • GSK Investigational Site

    Greater Manchester, United Kingdom · Recruiting

  • GSK Investigational Site

    Great Cambourne, Cambridge, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.